about
May Circulating microRNAs be Gastric Cancer Diagnostic Biomarkers?Long non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translationRole of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancerDecreased expression of eukaryotic initiation factor 3f is an adverse prognostic factor for stage I-III gastric cancer.High-Throughput miRNA Sequencing Reveals a Field Effect in Gastric Cancer and Suggests an Epigenetic Network Mechanism.Role of microRNAs in diagnosis and treatment of the pathogenesis of gastric cancer.Role of miR-100 in the radioresistance of colorectal cancer cells.MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met PathwayLower Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Promotes the Proliferation and Migration of Endometrial Carcinoma.miR-31 affects colorectal cancer cells by inhibiting autophagy in cancer-associated fibroblasts.Clinicopathologic Implications of Eukaryotic Initiation Factor 3f and Her-2/neu Expression in Gastric Cancer.The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancer.MicroRNA-370 suppresses the progression and proliferation of human astrocytoma and glioblastoma by negatively regulating β-catenin and causing activation of FOXO3a.MiRNA-150-3p targets SP1 and suppresses the growth of glioma cells.PLK1 as a potential prognostic marker of gastric cancer through MEK-ERK pathway on PDTX modelsAnnexin A1 Treatment Improves Skin Heterologous Transplantation by Modulating Inflammation and Angiogenesis Processes
P2860
Q26780339-BE80F49A-8E4A-4F0C-962A-3FEAF741C452Q26996377-A22F3863-C7A6-477F-B64E-0D209C4F97FFQ28067449-DAD7BF94-407D-40E6-9368-0AE4D0C1436EQ33715412-0B1892A1-4F86-42A6-8850-0BD6F9041240Q34488314-32C35555-E11D-486B-88D0-E2C1BB91387DQ35017521-67360B3E-45C2-435F-9DFE-EC86252AD4A5Q35402735-693E91D1-4038-4513-9950-71FA8B28CE53Q35694945-5CBCA6E0-5C42-4941-B010-0DDC34EC4DBBQ37677195-10EF5FDE-D092-4825-8B9D-DFFB29EFAF36Q37694824-66FB1C5D-FF87-4259-9707-20947AC9DF2DQ37700689-DD0DC65D-B7C4-457B-88A6-E48E2563A3C4Q38448187-F132FCBC-9629-4B05-A006-1F17B75BDDE9Q41991058-47014447-9316-466F-845E-BF57377514EAQ49335460-3B889A92-25E5-4BDB-808C-0CC86DE391CFQ55457308-19930DBF-1401-4D35-AFCF-D03828B94DD7Q57069974-C4D76CA4-C529-4174-85F6-8CA9A90DAABCQ58754242-22723275-DDF4-43EC-B1B7-D1ACBBAA4CA0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
miRNA: The nemesis of gastric cancer (Review).
@en
miRNA: The nemesis of gastric cancer
@nl
type
label
miRNA: The nemesis of gastric cancer (Review).
@en
miRNA: The nemesis of gastric cancer
@nl
prefLabel
miRNA: The nemesis of gastric cancer (Review).
@en
miRNA: The nemesis of gastric cancer
@nl
P2093
P2860
P356
P1433
P1476
miRNA: The nemesis of gastric cancer (Review).
@en
P2093
Chungen Xing
Jianping Cao
Shuyu Zhang
Xiaodong Yang
Xiaohui Xu
P2860
P304
P356
10.3892/OL.2013.1428
P577
2013-06-26T00:00:00Z